Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(7.69%)
USD 0.0
(7.69%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 62.83 Million | 52.9 Million | 39.98 Million | 31.43 Million | 21.19 Million | 151.85 Million |
| Cost of Revenue | 33.45 Million | 13.03 Million | 9.94 Million | 12.23 Million | 10.06 Million | 11.02 Million |
| Gross Profit | 29.38 Million | 39.87 Million | 30.04 Million | 19.19 Million | 11.12 Million | 140.83 Million |
| Operating Expenses | 403.56 Million | 407.91 Million | 231.57 Million | 214.37 Million | 140.6 Million | 88.49 Million |
| Selling, General and Administrative Expenses | 182.33 Million | 196.85 Million | 116.17 Million | 103.55 Million | 63.63 Million | 32.96 Million |
| Research and Development Expenses | 221.22 Million | 206.92 Million | 111.34 Million | 106.87 Million | 76.96 Million | 55.53 Million |
| Other Expenses | 130.13 Million | 4.14 Million | 4.05 Million | 3.94 Million | 3 Million | 2.61 Million |
| Cost and Expenses | 567.15 Million | 420.94 Million | 241.51 Million | 226.61 Million | 150.67 Million | 99.51 Million |
| Operating Income | -504.31 Million | -368.04 Million | -201.52 Million | -195.18 Million | -129.47 Million | 52.33 Million |
| Interest Expense | 8.57 Million | 10.22 Million | 20.18 Million | 36.13 Million | 57.63 Million | 4.98 Million |
| Income Tax Expense | -2.41 Million | -33.51 Million | -2.01 Million | -473 Thousand | -6.27 Million | -36.03 Million |
| Earnings before Tax | -561.74 Million | -462.52 Million | -310.58 Million | -359.57 Million | -213.78 Million | 15.31 Million |
| Net Income | -572.84 Million | -429.01 Million | -308.56 Million | -359.1 Million | -203.54 Million | 9.06 Million |
| Earnings Per Share Basic | -1.37 | -1.46 | -1.34 | -2.56 | -1.92 | 0.13 |
| Earnings Per Share Diluted | -1.37 | -1.46 | -1.34 | -2.56 | -1.92 | 0.13 |
| Weighted Average Shares Outstanding | 419.31 Million | 294.77 Million | 229.82 Million | 140.51 Million | 106.15 Million | 69.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 419.31 Million | 294.77 Million | 229.82 Million | 140.51 Million | 106.15 Million | 70.38 Million |
| Gross Margin | 0.47 | 0.75 | 0.75 | 0.61 | 0.52 | 0.93 |
| EBIT Margin | -8.59 | -7.25 | -4.80 | -5.83 | -5.68 | 0.39 |
| Profit Margin | -9.12 | -8.11 | -7.72 | -11.42 | -9.60 | 0.06 |
| EBITDA | -539.92 Million | -435.98 Million | -275.69 Million | -308.39 Million | -147.09 Million | 27.37 Million |
| Earnings Before Tax Margin | -8.03 | -6.96 | -5.04 | -6.21 | -6.11 | 0.34 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 15.02 Million | 16.25 Million | 62.83 Million | 15.59 Million | 17.4 Million | 11.46 Million |
| Cost of Revenue | 8.45 Million | 5.18 Million | 33.45 Million | 13.72 Million | 8.26 Million | 5.7 Million |
| Gross Profit | 6.57 Million | 11.06 Million | 29.38 Million | 1.87 Million | 9.13 Million | 5.75 Million |
| Operating Expenses | 83.33 Million | 99.91 Million | 407.88 Million | 81.63 Million | 119.27 Million | 97.63 Million |
| Selling, General and Administrative Expenses | 48.94 Million | 54.98 Million | - | 39.46 Million | 50.15 Million | 48.13 Million |
| Research and Development Expenses | 33.27 Million | 43.8 Million | - | 41.04 Million | 67.98 Million | 48.46 Million |
| Other Expenses | -4.32 Million | -76 Thousand | 4.32 Million | 1.12 Million | 1.12 Million | 1.03 Million |
| Cost and Expenses | 91.79 Million | 105.09 Million | 441.34 Million | 95.35 Million | 127.54 Million | 103.34 Million |
| Operating Income | -77.23 Million | -106.34 Million | -378.5 Million | -79.76 Million | -110.14 Million | -91.88 Million |
| Interest Expense | 2.66 Million | 1.13 Million | 8.57 Million | 2.21 Million | 792 Thousand | 2.31 Million |
| Income Tax Expense | 671 Thousand | 11.46 Million | -2.41 Million | -1.81 Million | -1.01 Million | -1.05 Million |
| Earnings before Tax | -107.86 Million | -142.79 Million | -561.74 Million | -210.49 Million | -91.7 Million | -220.59 Million |
| Net Income | -95.21 Million | -139.61 Million | -559.33 Million | -208.68 Million | -90.68 Million | -219.54 Million |
| Earnings Per Share Basic | -0.17 | -0.26 | - | -0.50 | -0.20 | -0.55 |
| Earnings Per Share Diluted | -0.17 | -0.26 | - | -0.50 | -0.20 | -0.55 |
| Weighted Average Shares Outstanding | 551.28 Million | 543.13 Million | 419.31 Million | 419.31 Million | 451.62 Million | 402.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 551.28 Million | 543.13 Million | 419.31 Million | 419.31 Million | 451.62 Million | 402.8 Million |
| Gross Margin | 0.44 | 0.68 | 0.47 | 0.12 | 0.52 | 0.50 |
| EBIT Margin | -5.16 | -5.25 | - | -4.81 | -6.13 | -7.80 |
| Profit Margin | -6.34 | -8.59 | -8.90 | -13.38 | -5.21 | -19.16 |
| EBITDA | -77.49 Million | -85.3 Million | - | -75.06 Million | -106.71 Million | -89.34 Million |
| Earnings Before Tax Margin | -5.14 | -6.54 | -6.02 | -5.12 | -6.33 | -8.02 |
API
BCNAY
300652
EKCS
CDMGF
301123